JPMorgan Chase & Co. (NYSE:JPM) Given Consensus Rating of “Moderate Buy” by Brokerages

JPMorgan Chase & Co. (NYSE:JPM) has been given an average recommendation of “Moderate Buy” by the twenty-eight brokerages that are presently covering the stock, MarketBeat Ratings reports. Eleven analysts have rated the stock with a hold recommendation, sixteen have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $359.9583.

JPM has been the subject of several research reports. HSBC raised their target price on JPMorgan Chase & Co. from $288.00 to $312.00 and gave the company a “hold” rating in a research note on Monday, May 4th. Truist Financial boosted their price target on shares of JPMorgan Chase & Co. from $344.00 to $352.00 and gave the company a “hold” rating in a report on Wednesday, July 15th. Keefe, Bruyette & Woods upped their target price on JPMorgan Chase & Co. from $370.00 to $384.00 and gave the company an “outperform” rating in a report on Wednesday, July 15th. Bank of America upped their price target on shares of JPMorgan Chase & Co. from $408.00 to $420.00 and gave the stock a “buy” rating in a research note on Thursday, July 16th. Finally, Wells Fargo & Company raised their price target on JPMorgan Chase & Co. from $375.00 to $390.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th.

JPMorgan Chase & Co. News Roundup

Here are the key news stories impacting JPMorgan Chase & Co. this week:

• Positive Sentiment: JPMorgan’s market-leading profitability and resilient earnings remain supportive. The bank recently reported earnings and revenue above consensus expectations, while analysts continue to project solid full-year earnings. JPMorgan Stock Falls as Treasury Yields Retreat
• Positive Sentiment: J.P. Morgan Life Sciences Private Capital appointed Bruce N. Rogers, Ph.D., as a venture partner, strengthening the firm’s specialist investment capabilities and potentially supporting long-term asset-management growth. J.P. Morgan Life Sciences Private Capital Appointment
• Neutral Sentiment: JPMorgan is reportedly among the lead underwriters arranging an expanded credit facility for Anthropic ahead of a potential IPO. The mandate could generate fees and reinforce JPMorgan’s investment-banking position, but it is unlikely to materially affect near-term earnings. Anthropic Pre-IPO Financing
• Neutral Sentiment: Articles continue to focus on succession risk after Jamie Dimon eventually steps down. His long tenure supports investor confidence, but the company’s scale and depth of management may limit the impact of any leadership transition. Jamie Dimon Succession Analysis
• Negative Sentiment: Retreating Treasury yields provided the clearest trading-related reason for JPMorgan’s weakness. Investors appear to be taking profits in the bank despite record earnings and strong trading revenue, while the stock’s proximity to its 52-week high may have increased sensitivity to selling. JPMorgan Stock Performance Analysis

JPMorgan Chase & Co. Stock Performance

JPM opened at $357.38 on Thursday. The business has a 50 day moving average price of $343.09 and a two-hundred day moving average price of $316.79. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market capitalization of $949.98 billion, a price-to-earnings ratio of 15.31, a price-to-earnings-growth ratio of 1.49 and a beta of 0.99. JPMorgan Chase & Co. has a 1-year low of $279.10 and a 1-year high of $366.50.

JPMorgan Chase & Co. (NYSE:JPM) last issued its quarterly earnings results on Tuesday, July 14th. The financial services provider reported $6.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.59 by $0.55. JPMorgan Chase & Co. had a return on equity of 18.23% and a net margin of 21.86%.The company had revenue of $58.02 billion for the quarter, compared to analysts’ expectations of $50.72 billion. During the same period last year, the firm earned $4.96 EPS. The firm’s revenue for the quarter was up 27.7% on a year-over-year basis. Research analysts predict that JPMorgan Chase & Co. will post 24.28 EPS for the current fiscal year.

Insider Transactions at JPMorgan Chase & Co.

In other JPMorgan Chase & Co. news, insider Robin Leopold sold 2,500 shares of the business’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $361.41, for a total value of $903,525.00. Following the completion of the sale, the insider owned 73,547 shares of the company’s stock, valued at $26,580,621.27. The trade was a 3.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Stacey Friedman sold 5,467 shares of the business’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $330.73, for a total value of $1,808,100.91. Following the completion of the sale, the general counsel owned 40,961 shares of the company’s stock, valued at approximately $13,547,031.53. This trade represents a 11.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.41% of the stock is owned by insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Timmons Wealth Management LLC acquired a new position in shares of JPMorgan Chase & Co. during the fourth quarter valued at about $27,000. Caitong International Asset Management Co. Ltd bought a new position in shares of JPMorgan Chase & Co. during the 4th quarter worth approximately $32,000. MBM Wealth Consultants LLC bought a new position in shares of JPMorgan Chase & Co. during the first quarter valued at $29,000. Aventus Investment Advisors Inc. bought a new position in JPMorgan Chase & Co. during the 2nd quarter valued at about $33,000. Finally, Osbon Capital Management LLC acquired a new position in JPMorgan Chase & Co. in the fourth quarter valued at about $35,000. 71.55% of the stock is currently owned by institutional investors and hedge funds.

JPMorgan Chase & Co. Company Profile

JPMorgan Chase & Co (NYSE: JPM) is a diversified global financial services firm headquartered in New York City. The company provides a wide range of banking and financial products and services to consumers, small businesses, corporations, governments and institutional investors worldwide. Its operations span retail banking, commercial lending, investment banking, asset management, payments and card services, and treasury and securities services.

The firm’s principal business activities are organized across several core lines: Consumer & Community Banking, which offers deposit accounts, mortgages, auto loans, credit cards and branch and digital banking under the Chase brand; Corporate & Investment Banking, which provides capital markets, advisory, underwriting, trading and risk management services; Commercial Banking, delivering lending, treasury and capital solutions to middle-market and corporate clients; and Asset & Wealth Management, which offers investment management, private banking and retirement services to institutions and high-net-worth individuals.